Press release
Autologous Fat Grafting Market Expected to Secure Notable Revenue Share during 2018-2026(Based on application type, the autologous fat grafting market is segmented as: Breast Augmentation Parts of the Face Buttocks Augmentation Other Parts of the Body)
Autologous Fat Grafting Market: IntroductionAutologous fat grafting is a minimally invasive method used for the removal of unwanted fat from one area of the body and re-injecting it into a desired area. Patients prefer this method of fat grafting because it is a natural and safe method.
New products have been developed with new technologies for the autologous fat grafting market. The fat tissues are extracted and harvested. Once the fat is harvested, it is cleaned and isolated through centrifuging. The centrifuge separates the undamaged cells from the damaged ones, and these are transplanted into the desired location.
The average time required for a fat grafting procedure is 30-40 minutes. Increase in the demand of aesthetic treatments from younger patients is expected to boost the autologous fat grafting market. Fat transfer is expected to be the future of aesthetic treatments. Autologous fat grafting is performed to restore a youthful facial appearance, enhance the lips or to fill in lines & creases that develop with age. Moreover, autologous fat grafting lasts longer in the non-movement areas such as under the eyes and sunken cheeks.
Request Free Sample Report@ https://www.factmr.com/connectus/sample?flag=S&rep_id=2701
Factors Driving the Autologous Fat Grafting Market
The procedure of transferring fat is not new, however, fat grafting has been developed in the recent past. Over 900,000 fat graft procedures were performed in 2015, according to the International Society of Aesthetic Plastic Surgery (ISAPS). Fat grafting also reduces allergic reactions and tissue rejections. Moreover, the influence of media and the film & fashion industries is also boosting the autologous fat grafting market. In addition, the rising prevalence of diseases, such as obesity and accidents, is boosting the number of treatments, which is also boosting the market. These procedures are also providing opportunities for a combination of treatments, which is also expected to increase the number of autologous fat grafting procedures.
Increase in the demand for natural and effective treatments by customers is also expected to boost the autologous fat grafting market. These procedures have the ability to treat the fine lines & wrinkles, due to which a larger number of people are likely to invest in them. The ability to perform breast augmentation through autologous fat grafting is also driving the market as it can be performed on women who are either unsuitable for implants or not wanting implants. Moreover, autologous fat transfer does not leave any scar on or under the breasts. However, the transfer of a large volume of fat is not advisable as the chances of the survival of the patient are lesser as compared to small transfer volumes.
Autologous Fat Grafting Market: Regional Outlook
Geographically, the global autologous fat grafting market is segmented into North America, Latin America, Europe, Asia-Pacific, Middle East & Africa, and Japan. North America is expected to be a dominant regional market for autologous fat grafting, followed by Europe, due an increase in the number of procedures in the U.S. as well as technological advancements in these procedures. Asia Pacific is expected to grow at a higher rate with growth in the number of awareness programs and the influence of the media. Japan is projected to be one of the leading countries in the autologous fat grafting market in the upcoming years. The Latin America autologous fat grafting market is also expected to witness significant growth during the forecast period.
Examples of some of the major players identified across the value chain of the autologous fat grafting market are Genesis Biosystems, Inc.; Galderma S.A.; Allergan; Integra LifeSciences Corporation; Sanofi; SciVision Biotech Inc.; Valeant and Ranfac Corp. These players in the autologous fat grafting market are forming collaborations to exploit the potential growth opportunities in the market. In addition, they are mainly focused on strengthening the core competencies of their product portfolio.
Autologous Fat Grafting Market: Segmentation
The autologous fat grafting market has been segmented on the basis of application, end users and geography.
Based on application type, the autologous fat grafting market is segmented as:
Breast Augmentation
Parts of the Face
Buttocks Augmentation
Other Parts of the Body
Based on end user, the autologous fat grafting market is segmented as:
Hospitals
Clinics
Short-stay Facility
Based on region, the autologous fat grafting market is segmented as:
North America
Latin America
Europe
Asia Pacific Excluding Japan
Japan
Middle East & Africa
Key data points covered in report
Request/View TOC@ https://www.factmr.com/connectus/sample?flag=T&rep_id=2701
The report covers exhaustive analysis on:
Autologous Fat Grafting Market by age group, end user and region
Regional level market analysis of North America, Latin America, Europe, Asia Pacific, Middle East & Africa by application, end user and country segments
Autologous Fat Grafting Market Dynamics & Opportunity Assessment
Historical Actual Market Size, 2013 - 2017
Autologous Fat Grafting Market system market Size & Forecast 2018-2028
Autologous Fat Grafting Market Current Trends/Issues/Challenges
Competition & Companies involved
Report Highlights:
Shifting Industry dynamics
In-depth market segmentation
Historical, current and projected industry size, and recent industry trends
Key Competition landscape, market structure, regulatory scenario
Epidemiology outlook for diseases
Economical spending, regional healthcare outlook, consumer healthcare expenditure
Availability of device, cost of the test, specificity and sensitivity
Strategies for key players and product offerings, channel strategies, regional foot print, channel footprint
Potential and niche segments/regions exhibiting promising growth
A neutral perspective towards market performance in terms of value and volume
Report Analysis@ https://www.factmr.com/report/2701/autologous-fat-grafting-market
About US
Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that’s why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
Rohit Bhisey
Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
Blog: https://factmrblog.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Autologous Fat Grafting Market Expected to Secure Notable Revenue Share during 2018-2026(Based on application type, the autologous fat grafting market is segmented as: Breast Augmentation Parts of the Face Buttocks Augmentation Other Parts of the Body) here
News-ID: 1746732 • Views: …
More Releases from Fact.MR
Heat Recovery Ventilator Market to Reach USD 8.9 Billion by 2035 - Growth Driven …
The global heat recovery ventilator market is projected to grow from USD 6.1 billion in 2025 to USD 8.9 billion by 2035, expanding at a compound annual growth rate (CAGR) of 3.8% during the forecast period, according to a new analysis by Fact.MR.
The growth is fueled by rising global energy efficiency standards, surging adoption of sustainable building technologies, and the increasing demand for indoor air quality solutions in both…
Global Glyoxal Market to Reach USD 2.79 Billion by 2035; Driven by Demand from T …
The global glyoxal market, valued at USD 1.66 billion in 2025, is forecast to reach USD 2.79 billion by 2035, expanding at a compound annual growth rate (CAGR) of 4.4%, according to the latest analysis by Fact.MR. Growth is driven by expanding applications in the textile and paper-based packaging sectors, where glyoxal's cross-linking and reinforcing effects enhance material strength, durability, and sustainability.
Key Market Indicators
Industrial Demand and Sustainability Momentum
Glyoxal serves as…
Global Isopropanol Market to Reach USD 4.6 Billion by 2035; Demand from Disinfec …
The global isopropanol market is projected to grow steadily from USD 3.6 billion in 2025 to USD 4.6 billion by 2035, expanding at a compound annual growth rate (CAGR) of 2.4%, according to the latest market analysis by Fact.MR. The study attributes this growth to the rising adoption of high-purity isopropanol in healthcare, pharmaceutical, and semiconductor applications, alongside expanding investments in bio-based and electronic-grade IPA production.
Data-Backed Growth Snapshot
Fact.MR's report, "Isopropanol…
Global Dimethicone Silicone Market to Reach USD 6.94 Billion by 2035; Asia-Pacif …
The global dimethicone silicone market is on track for sustained expansion, projected to increase from USD 4.43 billion in 2025 to USD 6.94 billion by 2035, growing at a compound annual growth rate (CAGR) of 4.6%, according to the latest study by Fact.MR. The surge is driven by robust demand in personal care, automotive, electronics, and industrial manufacturing applications, where dimethicone's unique thermal stability, lubrication, and sensory properties make it…
More Releases for Autologous
Transformative Trends Impacting the Autologous Cell Therapy Market Landscape: Te …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Autologous Cell Therapy Market Size By 2025?
The market size for autologous cell therapy has seen a swift expansion in the past few years. The growth is projected to increase from $10.28 billion in 2024 to $12.19 billion in 2025, at a compound annual growth…
Emerging Trends Influencing The Growth Of The Autologous Cell Therapy Market:Tec …
The Autologous Cell Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
How Big Is the Autologous Cell Therapy Market Size Expected to Be by 2034?
The Autologous Cell Therapy Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from…
Prominent Autologous Stem Cell And Non-Stem Cell Based Therapies Market Trend fo …
What Are the Projected Growth and Market Size Trends for the Autologous Stem Cell And Non-Stem Cell Based Therapies Market?
The market size for autologous stem cell and non-stem cell based treatments has experienced rapid expansion in recent years. In numerical terms, it is predicted to rise from $9.96 billion in 2024 to $11.59 billion in 2025, with a compound annual growth rate (CAGR) of 16.5%. The significant growth during the…
Autologous Cell Therapy Market Growth Outlook 2027
Transparency Market Research (TMR) has published a new report titled, 'Autologous cell therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is projected to expand at a CAGR of 18.1% from 2019 to 2027.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715
Overview
• Cell therapy also termed as cellular therapy…
Autologous Cell Therapy Market Insights Shared in Detailed Report
Transparency Market Research (TMR) has published a new report titled, 'Autologous cell therapy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019-2027'. According to the report, the global autologous cell therapy market was valued at US$ 7.5 Bn in 2018 and is projected to expand at a CAGR of 18.1% from 2019 to 2027.
Get Sample Copy of the Report @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=715
Overview
• Cell therapy also termed as cellular therapy…
Autologous Cell Therapy Market: High Prevalence of Cancer Triggers Demand for Au …
Global Autologous Cell Therapy Market: Overview
Autologous cell therapy refers to infusion or transfer of human tissue or cells back to the same person for treating a diseased part. For the same purpose, stem cells are removed from the patient, harvested, cultured, and once again transplanted to the same person. The purpose of this method is to reduce the chances of rejection to the treatment by the body. Furthermore, autologous cell…
